Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPESOLIMAB-SBZO Cause Generalised pustular psoriasis? 29 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Generalised pustular psoriasis have been filed in association with SPESOLIMAB-SBZO. This represents 14.7% of all adverse event reports for SPESOLIMAB-SBZO.

29
Reports of Generalised pustular psoriasis with SPESOLIMAB-SBZO
14.7%
of all SPESOLIMAB-SBZO reports
1
Deaths
3
Hospitalizations

How Dangerous Is Generalised pustular psoriasis From SPESOLIMAB-SBZO?

Of the 29 reports, 1 (3.4%) resulted in death, 3 (10.3%) required hospitalization.

Is Generalised pustular psoriasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPESOLIMAB-SBZO. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does SPESOLIMAB-SBZO Cause?

Drug ineffective (20) Rash (14) Pruritus (13) Fatigue (11) Psoriasis (10) Pustule (9) Headache (7) Urinary tract infection (7) Arthralgia (6) Condition aggravated (6)

What Other Drugs Cause Generalised pustular psoriasis?

ADALIMUMAB (14) DEXAMETHASONE (12) LEVOFLOXACIN (10) ACETAMINOPHEN (9) CYCLOSPORINE (8) DUPILUMAB (8) TERBINAFINE (8) CEFEPIME (7) HYDROXYCHLOROQUINE (7) IBUPROFEN (7)

Which SPESOLIMAB-SBZO Alternatives Have Lower Generalised pustular psoriasis Risk?

SPESOLIMAB-SBZO vs SPIRAMYCIN SPESOLIMAB-SBZO vs SPIRIVA SPESOLIMAB-SBZO vs SPIRONOLACTONE SPESOLIMAB-SBZO vs SPRYCEL SPESOLIMAB-SBZO vs STALEVO

Related Pages

SPESOLIMAB-SBZO Full Profile All Generalised pustular psoriasis Reports All Drugs Causing Generalised pustular psoriasis SPESOLIMAB-SBZO Demographics